Seaport Therapeutics Inc. Common Stock
SPTX | NASDAQ
$19.74
+$0.14 (+0.71%)
Nov 2, 2026, 10:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 46.04M |
Short-Term Investments | 169.94M |
Long-Term Investments | 17.67M |
Other Long-Term Assets | 2.88M |
Receivables | 3.03M |
Inventory | n/a |
Other Current Assets | n/a |
Total Current Assets | 223.23M |
Property-Plant & Equipment | 5.23M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 25.78M |
Total Assets | 249.01M |
Account Payables | 2.01M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 5.19M |
Total Current Liabilities | 12.78M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 325.33M |
Total Long-Term Liabilities | 328.77M |
Total Liabilities | 341.55M |
Total Debt | 5.08M |
Book Value | -92.55M |
Book Value Per Share | -2.39 |
Common Stock | 1K |
Retained Earnings | -114.11M |
Comprehensive Income | 301K |
Shareholders Equity | -92.55M |
Total Investments | 187.61M |
Add to Watchlist
Select watchlists to add or remove SPTX